|
ZNF667 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.850240E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.881600E-02 |
| Normal-vs-Stage2 |
7.389800E-02 |
| Normal-vs-Stage3 |
3.878700E-03 |
| Normal-vs-Stage4 |
1.389810E-02 |
| Stage1-vs-Stage2 |
5.727000E-01 |
| Stage1-vs-Stage3 |
9.761500E-02 |
| Stage1-vs-Stage4 |
2.037400E-01 |
| Stage2-vs-Stage3 |
5.969200E-01 |
| Stage2-vs-Stage4 |
7.189200E-01 |
| Stage3-vs-Stage4 |
8.916400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.397700E-02 |
| Normal-vs-AfricanAmerican |
4.133600E-01 |
| Normal-vs-Asian |
1.699880E-02 |
| Caucasian-vs-AfricanAmerican |
4.942800E-01 |
| Caucasian-vs-Asian |
4.527000E-01 |
| AfricanAmerican-vs-Asian |
2.374400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.736200E-02 |
| Normal-vs-Female |
1.704460E-02 |
| Male-vs-Female |
7.777400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.260760E-01 |
| Normal-vs-Age(41-60Yrs) |
3.967700E-02 |
| Normal-vs-Age(61-80Yrs) |
2.861900E-03 |
| Normal-vs-Age(81-100Yrs) |
9.368200E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.832000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.563800E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.143000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.307200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.252000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.742800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.408310E-02 |
| Classical-VS-Follicular |
1.824320E-02 |
| Classical-VS-Other |
7.789200E-01 |
| Classical-VS-Normal |
1.074230E-01 |
| Tall-VS-Follicular |
8.495000E-01 |
| Tall-VS-Other |
4.603000E-01 |
| Tall-VS-Normal |
3.855100E-03 |
| Follicular-VS-Other |
2.807000E-01 |
| Follicular-VS-Normal |
6.360400E-03 |
| Other-VS-Normal |
9.416000E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.570480E-02 |
| Normal-vs-N1 |
2.348200E-02 |
| N0-vs-N1 |
7.555400E-01 |
|
|
